Healio
Healio

Women in Ophthalmology Summer Symposium
ByJennifer Loh, MD
ByEamon N. Dreisbach
Fact checked byChristine Klimanskis, ELS

Read more

September 14, 2022
3 min watch
Save

VIDEO: Women show higher proportion of improvement than men after TearCare procedure

ByJennifer Loh, MD
ByEamon N. Dreisbach
Fact checked byChristine Klimanskis, ELS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses meibomian gland dysfunction in patients 1 month after TearCare treatment.

“While we know that the TearCare procedure (Sight Sciences) showed improvement in both males and females, there was a higher proportion of females that had improvement,” she said. “We think this is an important concept to know about, as we want to help all of our patients get better with their dry eye.”

Sources/Disclosures

Collapse
Source:

Loh J. Female subjects with meibomian gland dysfunction achieve superior symptom relief compared to males one month after single TearCare procedure. Presented at: Women in Ophthalmology Summer Symposium; Aug. 25-28, 2022; Monterey, California (hybrid meeting).

Disclosures: Loh reports receiving grant funding from Sight Sciences.

Read more about

meibomian gland
dysfunction
dry eye disease
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

 

Related Content